Healthcare / Biotech
Verily
30-Second Executive Brief
Executive Assessment
Verily functions as an established institution within Healthcare / Biotech, backed by 47% sourcing coverage, with a stable competitive position.
- Maintains 3 mapped relationships across the graph
- 47% sourcing coverage across sourced relationships
- Tracked as established institution within the Healthcare / Biotech category
Executive Snapshot
- Strategic Role
- Established Institution
- Sourcing Coverage
- 47%
- Ecosystem Influence
- High
- Strategic Momentum
- Insufficient Data
View Methodology →
Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.
Coverage
- Mapped Relationships
- 3
- Technology Domains
- 3
Strategic Implications
- Central node connecting multiple strategic ecosystems
- Directly influences technology and capital flows
- Material relevance to downstream dependency mapping
Top Opportunities
Top Risks
Critical Dependencies
Precision health AI company, formerly a wholly owned Alphabet subsidiary. Verily raised $300 million in March 2026 led by Series X Capital, with Alphabet becoming a minority (non-controlling) investor as the company transitioned from an LLC to a corporation (Verily Health Inc.), partnered with Samsung to connect its Pre platform with the Galaxy Watch8, and laid off 58 employees (about 4% of its workforce) in June 2026.
Sources
Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.
Evidence
1 source
- SiliconANGLE — Verily raises $300M, steps out from under Alphabet's shadownews
Acquisition & Investment Fit
AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.
Relationship Map
The relationships surrounding Verily — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.
Connection type
Click any node to make it the new center. Scroll to zoom, drag to pan.
The Story So Far
Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.
Verily's Timeline
A sourced, dated history of Verily's key moments — founding to present.
Mar 2026 · Raises $300M, Alphabet becomes minority investor
Verily raised $300 million led by Series X Capital, with participation from Alphabet, UCHealth and the University of Colorado Anschutz, with Alphabet becoming a minority investor as Verily transitioned from an LLC to a corporation named Verily Health Inc.
Mar 2026 · Partners with Samsung on Galaxy Watch8 integration
Verily announced a partnership with Samsung Electronics America to connect its precision health platform, Pre, with the Galaxy Watch8 to monitor real-world populations for research.